aMoon retweeted
Congrats to the Zebra Medical Vision Ltd team as they merge with Nanox Vision to form an innovative Israeli #radiology company combining cutting edge hardware, software and #artificialintelligence. lnkd.in/ddbGzzgy
aMoon retweeted
Congrats to Robert Habib, Nagi Habib and the superb team at MiNA Therapeutics for the recent deal signed with Eli Lilly and Company 🏆
aMoon Fund, Gur Roshwalb Omri Strul Tamar Farfel-Becker lnkd.in/dwH6azg
aMoon retweeted
With the close of our Series C financing, we will use proceeds to expand commercial efforts for our patient molecular signature test, PrismRA®, and data partnerships with payers, providers, and pharma. sciphermedicine.com/scipher-…
Congratulations to our partners at @IbexMedAx on raising a $38 million Series B financing, embarking on a new chapter in their journey to transform cancer diagnosis & pathology by harnessing #AI #technology at an unprecedented scale.
techcrunch.com/2021/03/09/ib…
aMoon retweeted
Proud to announce $38 million Series B, led by @OctopusVentures and @83Northvc. We embark on a new chapter in our journey to transform #cancer diagnosis by harnessing AI at an unprecedented scale. Read more ibex-ai.com/press/round-b-an… @DellTechCapital @aMoonFund #digitalpathology
On #InternationalWomensDay we celebrate the amazing talent, dedication & achievements of the women of aMoon!
We are proud & inspired by your commitment and ambition to accelerate cure!
The #HealthTech industry has much to look forward to in 2021!
Tomer Berkovitz, our Partner & CFO on this “industry #revolution” and some major events in our portfolio including Seer’s #IPO.
bloomberg.com/news/articles/…
Congratulations to Biolojic Design, Ltd. and Apple Tree Partners on the spin out and launch of Aulus - the novel breakthrough in #AI computationally designed anti-bodies IL-2.
endpts.com/michael-ehlers-is…
What's dawning on HealthTech’s horizon in 2021?
The rise of omics is transforming #LifeSciences Tools & Diagnostics from a sleepy segment to a booming industry that cuts across the #healthcare value chain and is revolutionizing delivery of #patientcare.
bit.ly/3rZvnwU
"It's about touching and improving lives".
Our Partner Moshe Mor spoke with @TheMarker about his recent move from #tech to #healthtech & the $100M raise for our early-stage Velocity Fund. @YSchindel
themarker.com/technation/.pr…
aMoon retweeted
Look what just landed... 🚀
amoon.fund lnkd.in/drYnAN4
aMoon retweeted
Roche, Roche Diagnostics USA lnkd.in/db_Azgg
aMoon retweeted
SOPHiA GENETICS - incredible company, exceptional leadership! Jurgi Camblong & Troy Cox - On behalf of myself, Tomer Berkovitz and the entire aMoon Fund team, we’re honored to partner with you to help accelerate genomics globally for the benefit of patien…lnkd.in/gzRu9Vf
aMoon retweeted
“#Alexa, do I have #COVID19?” Vocalis Health CEO Tal Wenderow speaks with @Nature on how vocal #biomarkers can help clinicians address the COVID-19 pandemic by triaging potential cases and identifying people who might be most in need of testing. Read more: nature.com/articles/d41586-0…
aMoon retweeted
Incredible to see MDClone & Intermountain Healthcare collaborating: (1) Saving lives and reducing morbidity for #chronickidneydisease patients (2) Identifying and engaging CKD patients to enable 86% avoidance in unplanned admissio…lnkd.in/du9pntd lnkd.in/dJNpd7p
We have some big news to share...
bloomberg.com/news/articles/…
aMoon retweeted
In pandemic era, entrepreneurs turn to SPACs, crowdfunding and direct listings tcrn.ch/2ZUjpr0 by @jshieber
aMoon retweeted
I am proud to announce that Zebra Medical Vision has received its fifth FDA (510k) clearance for our vertebral compression fractures (VCF) product. businesswire.com/news/home/2…
Our Managing Partner @YSchindel, a member of Israel's MOH task force on #COVID19, spoke to the @nytimes about the pandemic & #Israel’s latest serology initiative to determine the prevalence of antibodies to COVID-19.
Israel will begin conducting over the coming weeks a major effort to determine the prevalence of antibodies to Covid-19 by testing 100,000 people nyti.ms/3bc9pgu









